ProMIS Neurosciences
PMN • NASDAQ
ProMIS Neurosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Neil K. Warma, with a market cap of $132.2M.
CEONeil K. Warma
Next Earnings
Upcoming earnings announcement for ProMIS Neurosciences
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.69
Earnings History
Past 12 earnings reports for ProMIS Neurosciences
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$3.11Est: -$5.71 | +45.5% | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.24Est: -$0.30 | +20.0% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.29Est: -$0.22 | -31.8% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.21Est: -$0.12 | -75.0% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.02 | — | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | $0.31Est: -$0.07 | +542.9% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.13Est: -$0.14 | +7.1% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.19Est: -$0.20 | +5.0% | - | — | 10-Q |
| Apr 1, 2024 | Q4 2023 | -$0.09Est: -$0.17 | +47.1% | - | — | — |
| Nov 14, 2023 | Q3 2023 | -$0.19 | — | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.27 | — | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.58 | — | - | — | 10-Q |